Loss of mobility influences the quality of life for patients with neuromuscular diseases. Common measures of mobility and chronic muscle damage are the six-minute walk test and serum creatine kinase. Despite extensive pre-clinical studies of therapeutic approaches, characterization of these measures is incomplete. To address this, a six-minute ambulation assay, serum creatine kinase, and myoglobinuria were investigated for the mdx mouse, a dystrophinopathy mouse model commonly used in pre-clinical studies. mdx mice ambulated shorter distances than normal controls, a disparity accentuated after mild exercise. An asymmetric pathophysiology in mdx mice was unmasked with exercise, and peak measurements of serum creatine kinase and myoglobinuria were identified. Our data highlights the necessity to consider asymmetric pathology and timing of biomarkers when testing potential therapies for muscular dystrophy. Ó 2011 Elsevier B.V. All rights reserved.
Intr oduction
Duchenn e muscul ar dystro phy (DMD) is cau sed by mutation s in the X-linked dy strophin gene that lead to a complet e loss of dystr ophin express ion in muscle. Loss of dystrop hin express ion leads to a de crease in mob ility an d progres sive muscl e necrosi s in DMD. Init ial clinical diagnosi s is from the identi fication of muscl e weakne ss, elevated serum creat ine kinase (sCK) or the app earance of myoglo binuri a, and a muscle biopsy. A patien t endpoint measure commonl y used to assess mo bility and efficacy of a therape utic interv ention is the six-mi nute walk test. In pre-cl inical studies, common endpoint measur es to assess the efficacy of a potential therapy are sCK and histological analys is of muscl e patholog y. Current treatment s that impr ove en dpoint measur es in patien ts are lim ited. Part of the problem may be the design an d interpreta tion of pre-clini cal studies using the mdx mouse. This aspect is highlighted in three recent publica tions, demon strating publica tion bias in ba sic resear ch [1] , ove r-optimisti c or biased con clusion s from an imal models [2] , and the ne ed for quality pre-cl inical da ta [3] .
The mdx mo use, the an imal model commonl y used in pre-cl inical studi es for Duchenne mu scular dy strophy , lacks dy strophin due to a poin t mutat ion in the dystr ophin gene [4] . The mdx muscle patholog y is sim ilar to young DMD boys, but the clinical course is less severe than old er patie nts. Invest igation s using the mdx mou se have provided insigh ts into the comp lex mechan isms leading to muscl e degen eration, pro gression of muscle weakne ss, and clinical presenta tion of the disease . Our goal for this study was to refine three pre-cl inical endpoint measur es for the mdx mouse: the six-minute ambula tion assay, sCK, and myogl obinuri a. More accurat e pre-cl inical endpoint measur e for the mdx mice , used in conjunctio n with other refined end point measur es, will en hance the translatability of pre-cl inical data for DMD and possibly other loss of mo bility con ditions, to the clini c.
Materials and methods

Mice
The Jackson Labor atory mouse stra ins used in this study: C57BL /6J, B6. 129P2-Nos3 tm1Un c /J , B6.129S4-Nos1 tm1Plh /J, B6.129P2-Nos2 tm1Lau /J , and C57BL/ 10ScS n-Dm d mdx /J (abbreviated as C57BL/6, eNO S-null , nNOS-null, iNO S-null, and mdx, respectivel y). Other mice used were: B6.129Sv-Mb tmDj g and B6.129Sv-Utrn tmJrs (abbreviate d as Mb-null [5] an d Utrn-nu ll [6] , respect ively). Mb-null ;mdx, mdx;iNOS-null, mdx;nNO S-null , and mdx;Utrn-null mice were generat ed by intercross ing mice to produ ce mice on a mixed C57BL/6J; C57BL/10S cSnJ backg round. Phosp hodiest erase 5A inhibi tor treat ment for mdx mice was pr eviously describ ed [7] . To limit mild strain differences that cou ld be out bred [8] , mice were bred at the Universit y of Iowa to produ ce a large eno ugh numb er of mice from the same breeding pa ir for each coho rt of experi ments . To mini mize gender varia tion [8] , mice were male s at 10 weeks old unless otherw ise stated , and had food and water ad libitum wi th exposure to the same care handler. Mice were synchron ized, group hous ed, and test ed in rooms on the same shif ted 12:12-h light:dar k cycle. Testing time for all mice was at Zeitge ber time 14-17, when the mice were physiol ogically awake and active [9] . Mou se housing and activit y rooms were under specific pathogen -free co nditions . All mouse experi ments were performed in accordance with anima l usage guidel ines and regula tions set fort h by NIH an d the Un iversity of Iowa Insti tutional Animal Care and Use Com mittee. Mice were maint ained within a centralized barrier an imal faci lity at the Unive rsity of Iowa direct ed by the Office of Anim al Resour ces.
Six-m inute ambulati on dist ance test
Mou se activit y was monito red using the VersaMax Anim al Activity Monitor ing System as previou sly descri bed [7] . Mice wer e tested in individ ual chambers , for 6 Â 1 minut e intervals before and imm ediately after exercise. Data wer e trans ferred to a Microsoft Exc el worksheet and calcul ations were done within the Excel pro gram. For each minute of ambu lation, the average total dist ance was de termined an d standar d errors wer e calcul ated. The cumula tive distance per minute up to 6 min and the standard error for each minut e wer e charted.
Magnet ic resona nce imaging (MRI)
Mice were anesthe tized using a mixture of ketamine and xylazine (87.5 and 12.5 mg/k g, I.P.), and the plan e of an esthesia was confirmed by absence of the ped al reflex. For scans done afte r exercise, imaging star ted less than 10 min after exerci se to allow for mice to be anesthe tized. Image s were capture d in the axial an d coronal planes with a Varian Unity/Ino va 4.7 T smal l-bor e MRI system (Varian, Palo Alto, CA ), using an acquisi tion consis ting of T 2 -weight ed fast spin-e cho sequence (TR/TE = 5000/48 ms) with inplane resol ution of 0.11 Â 0.22 mm and sli ce thickne ss of 0.6 mm.
Treadm ill ex ercise
Mice wer e mildly exercised with an ad justable variab le-speed belt treadm ill from AccuP acer as previou sly describ ed [7] .
Contract ile propertie s of isolated musc le
Contract ile prop erties were measur ed for isol ated male mdx extenso r digit orum longus muscles from five unexercised or five post-exercised mice ages 16-19 weeks . Measurem ents post-exerci se were done wi thin 15-30 min after exercise. Mice were anesthe tized wi th an intr a-peritoneal injection of 1.3% avert in (0.015 ml/g body weigh t) an d muscles remove d. The proxim al tendo n was clamped to a post and the dist al tendon was tied to a dual mode servomotor (Aurora Scient ific) with 6-0 suture . Cont ractile propert ies, opt imal fiber lengt h an d maxi mal isom etric tetanic force, were determ ined as previous ly describ ed [10] . The length ening contrac tion protocol (LCP) was previously de scribed [11] . The force deficit was defined as the difference between pre-and post-LCP force express ed as a percent age of pre-LC P force [11] . P-valu e calculati ons were made us ing a Student t test.
Serum creat ine kin ase assay
Serum CK level s before and after exerci se wer e measured as previous ly descri bed [7] . For this study, blood collection an d assays were done at designa ted time points . To reduce variab ility in da ta sets [8] , all mice used were male, from the same breeding colony, and of the same age. The groups of mice test ed for Fig. 3A , F, G were from different breeding colonies . Normal sCK level s were 100-500 U/l. Elevat ed sCK levels were great er than 500 U/l and hyperCKemia values were co nsidered great er than 20,000 U/l. For blood colle ction, mice were placed in a restrainer , whi ch they freel y walk ed out of afte r blood colle ction. The initial drop of blood afte r the tail vein nick was wiped away and the subsequen t 25 ll of blood was co llected without tail manipul ation. Se rum was diluted 1:9 an d 1:49 (v:v), to ensure activit y level s within the lim its of the assay, and assaye d in triplic ate. Ther e was a minimum of 24 h between blood colle ctions from the same mouse. For sCK at different intervals , sCK from eight sets of mdx mice wer e measured 24 h prior to exercise. On test da y (0d), all eight sets of mice wer e exerci sed and sCK was assaye d 2 h post-exercise; 24 h follo wing the initial exerci se, the 1d set of mdx mice wer e run again and sCK was assaye d; the same proced ure was followe d for all other groups for subsequent interval days after the initial run. For sCK at different intervals within a 120-minu te time fram e after exerci se, nine sets of mice wer e used with each set of mice repres enting a time point.
Urine collecti on and dip sti ck assay
Urine was collected from each mouse by allow ing mice to ur inate over a fres h piece of aluminu m foil. Voided urine was trans ferr ed to a fres h micro centrifuge tube, the color noted, and tested immediat ely. Uri ne was applie d to the reagent strip (Siemens Mu ltistix Ò 10SG) in which the development of a blue color indica ted high level s of a heme protein. None of the mice had hemat uria.
Evans Blue Dye uptake imaging and quanti fication
Evans Bl ue Dye (EBD) injec tion was de scribed previously [12] . After 3 h, mice wer e run on a treadm ill. Mice were sacri ficed and quadriceps and gastr ocnemius muscles were collected. Axial 7 lm cryo-secti ons of skelet al muscle were visualized [12] . For qua ntification, each muscle was placed in 1 ml of N,N-dimethyl form amide for 48 h to extra ct the EBD . Absor ba nce of EBD in each solut ion was measur ed at 630 nm. Values wer e normal ized by dividing by the weight of the tis sue.
Statisti cal analys is
Unless otherw ise stated, the data were calcul ated acco rding to an analys is of varian ce. P-val ue calculati ons were made using a Student t test. Data are express ed as mean ± -SEM. See Table S1 for values , average s, and SEM for ambula tion.
Res ults
3.1. Ambula tion distance wi thin 6 min to meas ure mdx mouse perfo rmance
We combined and adapted the step-activit y mo nitor and six-mi nute wal k test in the form of a six-mi nute ambulation distan ce assay to asses s mou se perfor mance (Fig. 1 ).
Comparing basal ambula tory pe rformance over 6 min, we found that mdx mice show less ambula tory distan ce over 6 min than normal wild-type mice (Fig. 1A) . This difference in ambu lation perfor mance between mdx and wild-t ype mice parallels that of DMD and control boy s in the sixminute walk test [13] . Sin ce amb ulatory DMD boys are not sedenta ry like normal ly housed mdx mice , we en sured the clinic al relev ance of the ambula tory assay by physica lly challeng ing the mice before measur ing their ambula tory performan ce. As ambula tory DMD boys do not perfor m hard activities to exhau stion, the mdx mice were chall enged with mild an d limit ed treadm ill exercise, as previous ly describe d [7] , before ambula tion was asses sed. We ch ose this mil d, limit ed exerci se as opposed to an exhaust ive protocol, during their physiol ogical ly activ e tim e, to assay performanc e of acti ve mice , and not that of muscl e fatigue d mice. C57BL/6 mice showe d no significant difference in ambula tion before and afte r exerci se. How ever, wi th exercise, amb ulation of mdx mice was affected and the difference between wi ld-type and mdx mouse ambula tion distance was accentuated (Fig. 1B) . These ambula tion data clearly demon strate a distinct ion between control and mdx mouse pe rformance, particular ly afte r mild exerci se.
To vali date the ambu lation assay, we tested post-exercise perfor mance of other mouse models used to exami ne pathogeni c mechani sms of dystrop hin de ficiency. Const itutively active endotheli al and neu ronal nitr ic oxide synthas e (eNOS and nNOS, respect ivel y) enzymes play impor tant roles in vaso modulation , but only gen etic deletion of nNOS in mice leads to mdx-like de bility after mild exercise [7] . Basal ambulation dist ances of eNOS -null were simila r to that of wild-ty pe mice (Fig. S1A ). This sim ilarity is consistent with the indis tinguishabl e pre-ex ercis e vertical activity betw een wild-t ype and eNOS-and nNO S-null mouse strains [7] . Post-e xercise, howeve r, only nNOS-null mice displayed reduced ambu lation (Fig. 1C) . Previous repo rts show that geneti c ablation of nNOS in mdx mice doe s not alte r mdx muscl e pa thology [14, 15] and that the induction of iNOS express ion in mdx mice contribu tes to muscl e fiber damage [16, 17] . Comparat ive ambula tion dist ances from wild-t ype, mdx, mdx;iNO S-null, and mdx;nNOS-null mice de monstrated that geneti c ablation of iNO S or nNOS decreas ed mdx perfor mance afte r exerci se (Fig. 1D) , but had little effect on the basal ambula tion of mdx mice (Fig. S1B ) . Our resul ts from compari ng mdx an d mdx;nNO S-null ambula tion is consistent with our data compari ng pre-and post-exerci se acti vity of the same mice, which demonst rated that nNOS pertur bation affects performanc e [7] . Despi te report s that mdx;iNOS-null muscl e have less muscl e da mage [17] , their reduced ambula tion compared to mdx mice was con sistent with increa sed muscle patholog y in 6-and 10-week old mdx;iNOS-null mice (Fig. S2 ) . The mdx;Utrn-null mice showe d significant loss of ambula tion after mild exerci se (Fig. 1E ), con sistent with their more severe muscle patholog y [18] . Lastly, since we previous ly found that phos phodiest erase 5A inhibition was able to impr ove post-exercise vertica l acti vity [7] , we compared post-exercise ambula tion distan ce of control and mdx mice to that of mdx mice pre-t reated with phosph odiestera se 5A inhibi tor (Fig. 1F) . Phos phodiest erase 5A inhibi tor treatment impro ved mdx mouse ambula tion. These data demonst rate that the six-mi nute ambula tion assay is a highly respon sive test of diseas e severi ty and functi onal respon se with mdx mice .
Bilate ral analysis of mdx hind leg skeleta l musc les and asym metric pathol ogy
When mdx mice were treadm ill exerci sed, each mdx mouse, unlike wild-t ype con trols, consis tently leaned to one side of the treadmil l. Notably, mdx mice subjected to multiple round s of treadm ill exercise leaned to the same side for each run su ggesting that dy strophin deficiency causes asymm etric skeletal muscl e patholog y or weakne ss. To test this, we performed T 2 -w eighted MRI of wild-type and mdx mo use hind qua rters, without exercise an d after mild exercise (Fig. 2A) . Post-e xercise chan ges in T 2 -weight ed MRI show up as light er areas on scans an d indica te chan ges in wat er co ntent, which rep resent muscl e edema or inflammation. Corona l MRI scans of wild-t ype hind leg muscl es showe d no T 2 -weight ed changes ( Fig. 2A , wi ld-type pa nels). Corona l MRI scan s of mdx mice withou t exercise showe d no T 2 -weight ed changes, except some mice showe d smal l areas of fibrosis ( Fig. 2A , mdx no-ex, smal l arrowhead s). Corona l imag es of the same mdx mice all showe d a large increase in T 2 -weight ed changes after exerci se ( Fig. 2A , mdx post-ex, large arrowheads) that wer e always more in one leg than the con tralateral leg, even in older mdx mice (Fig. S3 ) .
The leani ng and somet imes unilateral app earance of T 2 -weight ed chan ges in mdx hind leg muscles suggest ed asymmetr ic patholog y and weakne ss. We exami ned mdx muscle damage by EBD. Dama ged or nec rotic muscl e fibers stai n pos itive for en dogenou s extra cellular protei ns like albumi n or IgG/M [4] . EBD binds albumi n. In une xercised mdx mice , muscl e fibers that stai n posit ive for EBD are also the one s that are positive for albumi n or mouse (F) C57BL/6 versus mdx treated with phosphod iesterase 5A inhibitor and untreated mdx mice (n = 6 for mdx, C57BL/6, nNOS-null, eNOS-null mice, and mdx + PDE5Ai; n = 4 for mdx;nNOS-null, mdx;Utrn-null, and mdx;iNOS-null mice. Error bars indicate SEM).
IgG/M [12, 19] . Thus , detection of EBD uptake into skeletal muscle is an accurate index of muscl e patholog y. To test asymm etric muscl e patholog y wi th mdx mice , we pe rform ed bilat eral exami nation of EBD stai ning in mdx quad riceps an d gastro cnemius muscles afte r exercise (Fig. 2B) . We found that EBD detect ion in the quad riceps and gastrocne mii muscl es was asymm etric in every mouse tested; in so me cases, onl y one side featu red detectable EBD/albu min uptake into muscl e (Fig. S3 ) . Quant itative ly, total EBD measur ement s co nfirmed varia ble EBD upt ake from each mdx mouse and asymm etrical EBD uptake in mdx qua driceps an d gastrocn emius muscl es afte r exerci se (Fig. 2C) . To test if this asymmetr ical patholog y translat ed to asymm etrical muscl e contrac tile pr operties, we compared the suscept ibilit y to contrac tion-ind uced injur y between the right an d left muscles of mdx mice (Fig. 2D) . Scans shown for no-ex and post-ex are from the same mouse. Localized areas of fibrosis (small white arrows) are detectable in mdx mice. T 2 -weighted changes (large white arrows) from mdx mice are indicative of muscle edema or inflammation (n = 5 for each). (B) Representat ive microscope images from bilateral analysis of quadricep s muscles (quads) and gastrocnemiu s muscles (gastrocs) from mdx mice post-exercise. Areas of Evans Blue Dye uptake into damaged muscle fibers (white arrows) and side the mouse leaned on are noted (n = 6). (C) Four mdx mice were I.V. injected with Evans Blue Dye then subjected to mild exercise. Quadriceps (quad) and gastrocnemiu s (gastroc) muscles were isolated separately. Total Evans Blue Dye was quantified for each muscle isolated . Measurem ents were done in triplicate, error bars are SEM. (D) Absolute differences in percent force deficits betwee n left and right mdx extensor digitorum longus muscles. Error bars are SEM. (*) Significant difference (P = 0.012) was observed between values for exercised mice compared with those of non-exercised mice.
For mice witho ut exercise and mice afte r exercise, isolated extens or digitorum longus muscle s wer e exp osed to a lengt hening contrac tion protocol and force deficit was determ ined. Exercis e height ened the dispar ity between right and left muscl es for su sceptibil ity to injur y. With exerci se, the more injur y-prone muscl es of each mouse incurr ed force deficits of 50 ± 4% which wer e typic ally two-fol d great er than the force deficits of the contra-lat eral muscl es, which average d 31 ± 3%. Thus , post-stretch force deficits wer e also asymmetr ic in mdx mice .
Timin g of indi ces of muscle pathology in mdx mice
Each time mdx exercised, they leaned to the same side. How ever, repeat ing the exe rcise did not significantly affect the post-exercise ambu lation perfor mance (Fig. 3A) . This lack of alteratio n in ambula tion afte r a repeated exercise suggest ed that there was no furt her muscl e damage oc curring. To test this, we first invest igated indice s of muscle damage and necrosi s by determini ng the peak analys is time for sCK in wild-t ype and mdx mice afte r ex ercise (Fig. 3B) . We found that sCK levels from mdx mice wer e generally elevat ed above control mo use levels witho ut exercise (Fig. 3B, 4903 .0 9 ± 443.76 U/l). After exe rcise, sCK consistentl y peak ed to hyperC Kemia levels 2 h after exercise (Fig. 3B, 55 ,850 .77 ± 55 23.04 U/l) and gradual ly dissipated to below pre-ex ercise sCK levels (Fi g. 3B, 565.45 ± 200.66 U/l) by 24 h. With wild-t ype mice , sCK reading s were con sistently below 500 U/l with a slig ht peak 1 h post-exercise. Wild-type sCK activity reading s went below pre-ex ercise levels by 6 h.
We assaye d the urine of mdx mice pre-and post-exerci se using urine dipsticks (Fig. 3C) . Simi lar to the pattern of sCK post-exerci se, heme de tection in mdx urine pe aked 2 h pos t-exerci se and dissipated by 6 h, with no evidence of he me in the urine by 24 h pos t-exerci se. To determine which heme protei n the dipst ick test was detect ing, we crosse d myogl obin-nul l (Mb-null) [5] an d mdx mice, then tested Mb-null;mdx mouse sCK and urine afte r mil d exercise (Fig. 3D, E) . Mb-null;mdx were negati ve for the presence of heme in their urine post-exerci se, but had elevated sCK before ex ercise and hyperCKem ia post-exerci se. Thus , a pos itive resul t on urine dipst icks from mdx mice indica tes that mdx mice have exerci se-indu ced myo globinur ia, which corres ponde d wi th hyp erCKemi a level s.
Consist ent with no signi ficant chang e in mdx amb ulation pe rformance, mdx sCK levels did not increa se as it did during the initial exerci se. We repeated the mil d exercise with different sets of mdx mice at 1, 3, 5, 7, 9, 11, 13, and 14 days after the initial exerci se, and measur ed sCK at the 2 h time point (Fig. 3F) . After the rise in sCK to hy perCK levels follo wing the first bout of exerci se on day 0 (0d), sCK from the mdx mice rose to that same level only when the inter val betw een exercise was 14 days. Myoglobinuria followe d the same pa ttern (Fig. 3F, inset ) .
To test for early peak ing of sCK , we exerci sed mdx mice twice in a 24 h interval, and colle cted sCK at severa l time points up to 2 h followin g the second bout of exerci se (Fig. 3G) . Twent y-four hour s since an initial mild exerci se, different sets of mdx mice wer e mild ly exercised again and sCK was measur ed at time interva ls post-exerci se (0, 15, 30, 45, 60, 75, 90, 105, and 120 min). Different sets of mice were used for each time point. Readi ngs for sCK remai ned relative ly close to elevated pre-ex ercise level s within each time poi nt, consistent wi th ongo ing regener ation. At the 2 h mark, sCK reading s were the low est. Myoglobi nuria was undetect able dur ing this 2 h analys is (Fig. 3G, inset ) .
Discuss ion
The mdx mouse is extens ively used as the pre-cl inical anima l mod el for dystr ophin deficiency to investiga te therapeuti c approa ches for DMD. Ther e are pr omising therapeutic inter ventio ns emerg ing for DMD that are in Phas e I/II clinical tri als like exon skippi ng, myost atins, an d co mpounds that up-regul ate utrop hin [20] . Despi te these recent advances, there are a multit ude of poten tial therapi es that have not succ eeded in clinic al trials, current ly leavi ng patien ts with no cu rative treatment . This discrep ancy has caused resear chers to questio n the mdx mouse as a model for DMD as wel l as the vali dity of trans lating promi sing results from mdx pre-clini cal studi es into clinical trials. Our data de monst rate that when pro perly assaye d, the mdx mo use is an ideal model for pre -clinical studi es for DMD.
A six-mi nute ambula tion test was designe d for mice as an endpo int measur e for DMD pre-cl inical studi es. Timed submaximal exerci se perfor mance is us ed as a standar d outcome measur e in clinical trials to test the efficacy of a treatment on impr oving mobility . Thi s mild exerci se is used for a variety of diseases in which patien ts experien ce phy sical limitations . The step-activit y mo nitor and six-mi nute walk test are two form s of this kind of testing that are used with normal and ambulatory DMD boy s [13, 21] . We combined these two assays into the six-min ute ambula tion dist ance test for mice . Like with DMD boy s, mdx mice showe d reduced ambulation. The reduced ambula tion of the mdx;i-NOS-null mouse was a surpri se, but not so when we found that the muscl es were consistentl y more fibrotic than mdx muscles. Our mdx;iNOS-nu ll data su ggest that some iNOS activit y is ne cessary during the deg eneration-r egenerat ion of dystr ophic muscl e to prevent extens ive muscl e fibrosis. The redu ced ambula tion of the mdx;nNOS-nu ll mice after mild exercise is in line with our previous findings of lower post-exerci se vertical acti vity with these mice [7] , and is also consis tent with a repo rt that shows myo pathic fun ctional deficits with reduced bulk and impai red co ntractil e functi on in nNOS-deficient mu scle [22] . The increa sed perfor mance in the six-minute amb ulation assay of mdx mice treat ed with phosph odiesterase 5A inhibi tor was consistent wi th our previous da ta that this acute pre-t reatment increa ses mdx post-exerci se vertica l acti vity [7] . This pha rmacolo gical treatment along with the other mdx mou se models used in this study vali dated the six-mi nute ambula tion assay as a perfor mance outcome measur e for DMD pre-cl inical studies using the mdx mou se. In add ition, we de monstrated that after mild exercise with the mdx mo use, this assay is responsive to varying degrees of muscle pa thology in that ambulation increa sed or de crease d wi th known chan ges in muscle functio n among the different mdx mouse models and with a pharmac ologic al treat ment.
The co mbination of the exercise an d ambula tion assay provided severa l informat ive pieces of da ta. The red uced ambula tion with mdx mice is in agreem ent with previous studi es that show mdx mice have reduced locomot or acti vity based on a SHIR PA test [23] and reduced volunta ry running compared to their wild-t ype counterpar ts [24] [25] [26] [27] . Even the leanin g of mdx mice dur ing exerci se on the treadm ill was not too surpri sing since it is sim ilar to what ambula tory DMD boys do to maint ain balance and ga it while walking [28] . Wha t was impor tant to this observat ion of leanin g to one side of the treadmil l was that we did bilateral analysis of muscl e pa thology and found mdx mice have asymmetr ic muscl e pa thology in their quadriceps an d gastrocnem ius skelet al muscl es and ha ve asymmetric muscl e force. Thes e findings are signi ficant, as several therape utic studies for DMD use muscle pa thology as an en dpoint measure , and many therape utic pre-cl inical studi es test one leg of an mdx mouse and use the contra-lateral leg as a con trol.
The asymmetr ic mdx muscl e pa thology may be simila r to the varia bility in dy strophin opathy patien ts, with some muscles being affected while ne ighbori ng, or oth er muscl es being spared from patho logy. Like with human s, mice have a Fig. 3 . Post-exercise ambulatio n, serum creatine kinase (sCK), and myoglobinu ria. (A) Six-minute ambulatio n distance post-exerci se and after a repeated exercise 24 h later (n = 4). (B) Serum CK from C57BL/6 and mdx mice before (pre) and at different time points after exercise (n = 4 for each). (C) The presence of heme in the urine was assesse d using urine dipsticks. Key for heme amounts is displayed (n = 3 for each). (D) Urine collected pre-and postexercise from littermate mdx and Mb-null;mdx mice were tested on dipstick strips (n = 3 per analysis ). (E) Serum CK before and 2 h after exercise from Mb-null;mdx mice (n = 4). (F) After an initial bout of exercise, eight sets of mdx mice, at different intervals (1d, 3d, 5d, 7d, 9d, 11d, 13d, and 14d), were reexercised and sCK was measured (0d n = 40, 1d n = 5, 3d n = 5, 5d n = 6, 7d n = 4, 9d n = 4, 11d n = 3, 13d n = 6, and 14d n = 7), and myoglobi nuria was tested (inset). (G) Nine sets of mdx mice were exercised and then 24 h later were exercised again. Each set of mice represen ted a time point. Serum CK was assayed at T = 0, 15, 30, 45, 60, 75, 90, 105, and 120 min after the repeated exercise. (T = 0, n = 11; T = 15, n = 6; T = 30, 45, and 60, n = 6; T = 75, 90, 105, and 120, n = 4), and myoglob inuria was tested with represent ative results in the inset. Error bars are SEM. lateral prefer ence [29] , i.e. display han dedness, but in general ly, most mouse stra ins show an equal distribut ion of right-and left-han dedness [30, 31] . Whether this late rality influences mdx phy siopatho logy and suscept ibility to contrac tion-induced injury or muscle patholog y influences th e la te ra li ty of md x mi ce , re ma in s unk no wn . In na te la te ra li ty could influence mdx patho logy, wher eby the dom inant side gets more use than the other and eventual ly becomes more severe ly affected. Conver sely, asymm etric mdx muscle patholog y could influence late rality. Clinic ally, muscle weakne ss in DMD pa tients is often describ ed as symmetri c, in that both left and right sides will show muscl e weakne ss. How ever, DMD patie nts do have asymm etric muscl e weakness. The weakne ss is symmetric al in that both sides sho w muscl e weakne ss, but the de gree of left to right weakne ss may be variable. The varia bility could be due to handedn ess or to a learne d ada ptive response. Whether there is asymmetric muscle patholog y with DMD patients is unknow n as syst ematic bilate ral an alysis of skelet al muscle would requir e mult iple mu scle biop sies that woul d be difficult to ethic ally justify. Neverthele ss, our findings demonst rate that asymm etric muscle patholog y as well as asymm etric weakness sho uld be consider ed when taking biopsi es for testing therapi es in an imal mod els, pa rticular ly the mdx mouse.
The ongoing necrosis of skeletal muscl e and the asymmetric patholog y and weakne ss could contrib ute to the reduced ambula tion and leanin g during exerci se of mdx mice . If an mdx mouse leaned to one side during the treadmill exercise, the same mou se woul d lean to the same side when the treadmil l exerci se was repeat ed. In addition, repeat ing the exe rcise with the same mou se the next day did not signi ficantly affect the post-exerci se ambu lation perform ance. Consist ent with no ch ange in ambula tion performance, mdx sCK level s did not increa se as it did during the initial exerci se. Despi te each skeletal muscl e fiber be ing suscepti ble to co ntraction-induced injury due to the lack of dystr ophin, an d ch ronic inflammation in the mdx mouse [32] , this lack of increa se in sCK afte r subsequen t exercise suggest ed that repe at exercise does not result in furthe r muscl e damage. The relea se of CK and myoglo bin from normal muscle , howeve r, is though t to acti vate an inflammator y response that enhances clear ance of these protei ns, such that subsequent muscle damage fails to give rise to elevated muscle-cel l protei ns in the blood [33] [34] [35] . We found no evidence of sCK or myogl obinuri a peaking sooner. It is not clear why biomar kers of muscl e damage follow this patte rn. Never thele ss, our data demonst rate the importance of mouse activity and analys is time for these muscl e damage biomar kers. If the normal ly sed entary mdx mouse is active one to fourtee n days be fore a sCK an alysis, sCK level s will likely be lower than expecte d when an alyzed. Thus , a low sCK read ing in an mdx mouse pre-cl inical study may not be a response to the therape utic agent, but sim ply a reflection of mouse activit y during the trial period.
In summ ary, we present the use of a six-minute ambula tion test, in co njunctio n with refined an alyses of muscl e patholog y and biomar kers of muscle da mage, as pre-clini cal endpo int measur es relev ant for muscul ar dystrophy pre-cl inical tri als us ing mdx mice . Future pre-cl inical study designs for muscular dystrop hy sho uld take into account possibl e baseli ne asymm etry of muscl e patholog y. Our data is con sistent with other report s that descri be physiol ogical function being altered after performan ce testing wi th mdx mice [23] , thus sCK level s can also be affected by pre-sCK assessment exercise and /or activit y. Ther efore, future study designs should consider the circadian rhythm and mouse acti vity in mou se phy siolo gical perfor mance analys es before muscle damage biomar kers are assaye d. Positive findings us ing these end point measur es may enhance the trans latab ility of futur e pre-cl inical studi es for Duchen ne an d oth er muscul ar dy strophies.
